Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2023, 32(2):138-141

Prediction of left ventricular reverse remodelling. Mini review on clinical aspects

Chudy M, Goncalvesova E
Department of Heart Failure and Transplantation, Faculty of Medicine, Comenius University and National Cardiovascular Institute, Bratislava, Slovakia

Uverejnené: February 1, 2023  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chudy M, Goncalvesova E. Prediction of left ventricular reverse remodelling. Mini review on clinical aspects. Cardiology Letters. 2023;32(2):138-141.
Share...
Stiahnuť citáciu
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobraziť celý článok

    Referencie

    1. Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 Aug;76:719-734. Prejsť k pôvodnému zdroju...
    2. He Y, Ling Y, Guo W, Li Q, Yu S, Huang H, et al. Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021 Nov 25;8:757596. Prejsť k pôvodnému zdroju...
    3. Merlo M, Pyxaras S, Pinamonti B, G B, A DL, G S. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011 Mar 29;57:1468-1476. Prejsť k pôvodnému zdroju...
    4. Ye L, Li X, Wang S, Wang Y, Zheng Y, Wang L. Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure. Front Cardiovasc Med. 2021 Dec 1;8. Prejsť k pôvodnému zdroju...
    5. Wilcox JE, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Heywood JT, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF. Am Heart J. 2012 Jan 1;163:49-56. e2. Prejsť k pôvodnému zdroju...
    6. Florea VG, Rector TS, Anand IS, Cohn JN. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival. Circ Hear Fail. 2016 Jul 1;9: e003123. Prejsť k pôvodnému zdroju...
    7. Lupón J, Gaggin H, de Antonio M, M D, A G, E Z, et al. Biomarkerassist score for reverse remodeling prediction in heart failure: The ST2-R2 score. Int J Cardiol. 2015;184:33-343. Prejsť k pôvodnému zdroju...
    8. Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, et al. Left ventricular reverse remodeling in dilated cardiomyopathy-maintained subclinical myocardial systolic and diastolic dysfunction. Int J Cardiovasc Imaging. 2017 May 1;33:605-613. Prejsť k pôvodnému zdroju...
    9. Choi JO, Kim EY, Lee GY, Lee SC, Park SW, Kim DK, et al. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J. 2013;77:462-469. Prejsť k pôvodnému zdroju...
    10. Park SM, Kim YH, Ahn CM, Hong SJ, Lim DS, Shim WJ. Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy. Eur J Echocardiogr. 2011 Dec;12:887-894. Prejsť k pôvodnému zdroju...
    11. Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013 Sep;6:790-799. Prejsť k pôvodnému zdroju...
    12. Barison A, Aimo A, Ortalda A, Todiere G, Grigoratos C, Passino C, et al. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. Int J Cardiol. 2018 Jan 1;250:195-200. Prejsť k pôvodnému zdroju...
    13. Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, et al. Biomarkers in heart failure: the past, current and future [Internet]. Heart Failure Rev. 2019: 24:867-903. Prejsť k pôvodnému zdroju...
    14. Gaggin HK, Szymonifka J, Bhardwaj A, Belcher A, De Berardinis B, Motiwala S, et al. Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure. JACC Hear Fail. 2014 Feb;2:65-72. Prejsť k pôvodnému zdroju...
    15. Basuray A, French B, Ky B, Vorovich E, Olt C, Sweitzer NK, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014 Jun 10;129:2380-2387. Prejsť k pôvodnému zdroju...
    16. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, Burkman G, Siwamogsatham S, Patel A, et al. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol. 2016 Aug 1;1:510-518. Prejsť k pôvodnému zdroju...
    17. Wohlfahrt P, Nativi-Nicolau J, Zhang M, CH S, T G, J C, et al. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol. 2021;E1-6. Prejsť k pôvodnému zdroju...

    Späť na obsah